THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Mass. to get life-science giant

Spinoff counters trend of losing local firms to out-of-town buyers

By Stephen Heuser
Globe Staff / January 25, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

With the sweep of a federal regulator's pen, Massachusetts stands to gain a new life-science giant in April: Covidien , a medical-supplies maker with thousands of products and more than 43,000 employees worldwide. (Full article: 870 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly